Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY TARGETING PD-L1 AND VEGF AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/032664
Kind Code:
A1
Abstract:
Provided are an antibody targeting PD-L1 and VEGF and use thereof. Also provided is an antigen-binding protein, comprising a first targeting moiety and a second targeting moiety. The first targeting moiety has the function of specifically binding to PD-L1, and the second targeting moiety has the function of specifically binding to VEGF.

Inventors:
WANG ZONGDA (CN)
GU CHUNYIN (CN)
DENG SUJUN (CN)
Application Number:
PCT/CN2023/112026
Publication Date:
February 15, 2024
Filing Date:
August 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI JEMINCARE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/46; A61K39/395; A61P35/00
Domestic Patent References:
WO2022042719A12022-03-03
Foreign References:
CN113214400A2021-08-06
CN109476762A2019-03-15
CN109575140A2019-04-05
CN109942712A2019-06-28
Other References:
ZHAO MENGZE, LI FENG-ZHI; WANG PENG-YIN; LI JIAN; XU HAN-MEI: "Research Progress of Dual-target Blocking Therapy of PD-L1 and VEGF", CHINA BIOTECHNOLOGY, vol. 41, no. 9, 31 December 2021 (2021-12-31), pages 71 - 77, XP093138810, DOI: 10.13523/j.cb.2105017
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF: